Due to shortages, EpiPen expiration dates have been extended by the FDA
The U.S. Food and Drug Administration announced Tuesday that it’s extending the expiration date for some EpiPens.
The move comes in the wake of EpiPen shortages.
Epipens are auto-injectors that deliver epinephrine to help treat life-threatening allergic reactions. According to pharmaceutical company Pfizer, the expiration extension applies to specific lots.
It includes EpiPen 0.3 milligram auto-injectors and the authorized generic version.
They have expiration dates between April 2018 and December 2018.
In its statement, the FDA noted that it continues to work closely with pharmaceutical company Mylan on production and supply.
The FDA also announced last week it has approved the first generic version of EpiPen, which will be available in the coming months.